Evaluation of the effect of Althaea officinalis ointment in chronic low back pain relief

Comparison of the analgesic effects of Topical application Althaea officinalis ointment and Piroxicam gel in patients with chronic low back pain

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210216050387N1

Enrollment

110

Registered

2021-03-27

Start date

2021-04-21

Completion date

Unknown

Last updated

2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

low back pain. Low back pain

Interventions

Intervention 1: Intervention group: 2.5 gr of 20% Althaea officinalis ointment produced in the laboratory of medicinal plants of Fasa University of Medical Sciences used topically twice a day for each

Eligibility

Sex/Gender

All

Age

20 Years to No maximum

Inclusion criteria

Inclusion criteria: Patient informed consent Doctor's approval Back pain for more than three months Pain intensity higher than 3 on the Visual Analogue Scale Score higher than 4 in the Roland-Morris Disability Questionnaire

Exclusion criteria

Exclusion criteria: Having surgery, fractures, dislocations and sprains in the spine Diseases such as osteoporosis, osteoarthritis, cancer, rheumatism, disc herniation, sciatica, inflammatory diseases, malignant tumors Nervous system diseases and spinal cord injuries Skeletal malformation Severe structural disorder of the lower limbs and spine Pregnancy Injectable analgesics and corticosteroids

Design outcomes

Primary

Measure	Time frame
Pain intensity. Timepoint: Beginning of the intervention - end of the intervention and 2 weeks after the end of the intervention. Method of measurement: Visual Analogue Scale.	—

Secondary

Measure	Time frame
Functional Disability. Timepoint: Before intervention - end of the intervention. Method of measurement: Roland-Morris Disability Questionnaire.;Blood pressure. Timepoint: Before intervention - end of the intervention. Method of measurement: Aneroid Sphygmomanometer.;Oxygen saturation. Timepoint: Before intervention - end of the intervention. Method of measurement: Finger Pulse Oximeter.;Pulse rate. Timepoint: Before intervention - end of the intervention. Method of measurement: Finger Pulse Oximeter.;Respiratory rate. Timepoint: Before intervention - end of the intervention. Method of measurement: Stopwatch.	—

Measure

Time frame

Functional Disability. Timepoint: Before intervention - end of the intervention. Method of measurement: Roland-Morris Disability Questionnaire.;Blood pressure. Timepoint: Before intervention - end of the intervention. Method of measurement: Aneroid Sphygmomanometer.;Oxygen saturation. Timepoint: Before intervention - end of the intervention. Method of measurement: Finger Pulse Oximeter.;Pulse rate. Timepoint: Before intervention - end of the intervention. Method of measurement: Finger Pulse Oximeter.;Respiratory rate. Timepoint: Before intervention - end of the intervention. Method of measurement: Stopwatch.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Leila Nikrouz

Fasa University of Medical Sciences

L.nikrouz@fums.ac.ir+98 71 5335 0994

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026